Рецепт. 2018; : 786-797
Лечение ревматоидного артрита, ассоциированного с инфекцией Chlamydophila pneumoniae
Аннотация
Несмотря на внедрение в ревматологическую практику генно-инженерных биологических препаратов, обладающих мощным иммуносупрессивным эффектом и с успехом при- меняющихся для лечения разнообразной ревматической патологии как у нас в стране, так и за рубежом, ревматоидный артрит по-прежнему остается чрезвычайно сложной проблемой для ревматологов во всем мире. В ситуациях, когда традиционная противовоспалительная терапия оказывается малоэффективной, гипотеза ассоциации инфекции и ревматоидного артрита становится актуальной. Согласно современным данным, одним из патогенов, с которым может быть ассоциирован артрит и который может влиять на течение и эффективность лечения ревматоидного артрита, является Chlamydophila pneumoniae. В статье представлены результаты комплексного лечения ревматоидного артрита, ассоциированного с инфекцией Chlamydophila pneumoniae.
Список литературы
1. Kunder E. (2015) Reaktivnyy artrit [Reactive arthritis]. Meditsinskiye novosti, no 11, pp. 8-13.
2. Belov B., Shubin S., Balabanova R., Erdes Sh. (2015) Reakctivnyye artrity [Reactive arthritis].
3. Nauchno-Prakticheskaya Revmatologiya, vol. 53, no 4, pp. 414-420.
4. Zeidler H., Hudson A.P. (2016) Causality of Chlamydiae in arthritis and spondiloarthritis: a plea for increased translational research. Curr. Rheum. Rep., vol. 18, no 9, pp. 10. doi: 10.1007/s11926- 015-0559-3.
5. Rihl M. (2016) Update in reactive arthritis. Z Rheumatol., vol. 75, no 9, pp. 869-877.
6. Wilkinson N.Z. (1998) Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum., vol. 41, no 5, pp. 845-854.
7. Schumacher H.R. (1999) Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum., vol. 42, no 9, pp. 1889-1893.
8. Gérard H.C. (2000) Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb. Pathog., vol. 29, no 1, pp. 17-24.
9. Cascina A. (2002) Cutaneous vasculitis and reactive arthritis following respiratory infection due to Chlamydia pneumoniae: report of a case. Clin. Exp. Rheum., vol. 20, no 6, pp. 845-847.
10. Takeda H.J. (2002) A patient with adult Still’s disease with an increased Chlamydia pneumoniae antibody titer. Infect. Chemother., vol. 8, no 3, pp. 262-265.
11. Ardeniz O. (2005) Chlamydia pneumoniae arthritis in a patient with common variable immunodeficiency. Ann. Allergy Asthma Immunol., vol. 94, no 4, pp. 504-508.
12. Contini C. (2011) Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value. Rheum. Int., vol. 31, no 10, pp. 1307-1313.
13. Feng X.G. (2011) Recent Chlamydia pneumoniae infection is highly associated with active ankylosing spondylitis in a Chinese cohort. Scand. J. Rheum., vol. 40, no 4, pp. 289-291.
14. Rizzo A. (2012) The role of Chlamydia and Chlamydophila infections in reactive arthritis. Intern. Med., vol. 51, no 1, pp. 113-117.
Recipe. 2018; : 786-797
Treatment of rheumatoid arthritis associated with Chlamydophila pneumoniae infection
Abstract
References
1. Kunder E. (2015) Reaktivnyy artrit [Reactive arthritis]. Meditsinskiye novosti, no 11, pp. 8-13.
2. Belov B., Shubin S., Balabanova R., Erdes Sh. (2015) Reakctivnyye artrity [Reactive arthritis].
3. Nauchno-Prakticheskaya Revmatologiya, vol. 53, no 4, pp. 414-420.
4. Zeidler H., Hudson A.P. (2016) Causality of Chlamydiae in arthritis and spondiloarthritis: a plea for increased translational research. Curr. Rheum. Rep., vol. 18, no 9, pp. 10. doi: 10.1007/s11926- 015-0559-3.
5. Rihl M. (2016) Update in reactive arthritis. Z Rheumatol., vol. 75, no 9, pp. 869-877.
6. Wilkinson N.Z. (1998) Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum., vol. 41, no 5, pp. 845-854.
7. Schumacher H.R. (1999) Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum., vol. 42, no 9, pp. 1889-1893.
8. Gérard H.C. (2000) Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb. Pathog., vol. 29, no 1, pp. 17-24.
9. Cascina A. (2002) Cutaneous vasculitis and reactive arthritis following respiratory infection due to Chlamydia pneumoniae: report of a case. Clin. Exp. Rheum., vol. 20, no 6, pp. 845-847.
10. Takeda H.J. (2002) A patient with adult Still’s disease with an increased Chlamydia pneumoniae antibody titer. Infect. Chemother., vol. 8, no 3, pp. 262-265.
11. Ardeniz O. (2005) Chlamydia pneumoniae arthritis in a patient with common variable immunodeficiency. Ann. Allergy Asthma Immunol., vol. 94, no 4, pp. 504-508.
12. Contini C. (2011) Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value. Rheum. Int., vol. 31, no 10, pp. 1307-1313.
13. Feng X.G. (2011) Recent Chlamydia pneumoniae infection is highly associated with active ankylosing spondylitis in a Chinese cohort. Scand. J. Rheum., vol. 40, no 4, pp. 289-291.
14. Rizzo A. (2012) The role of Chlamydia and Chlamydophila infections in reactive arthritis. Intern. Med., vol. 51, no 1, pp. 113-117.
